# BrightSpring Health Services, Inc.: filings

BTSG · Nasdaq · CIK 1865782 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/btsg.md) · [Financials](/companies/btsg/financials.md) · [Filings](/companies/btsg/filings.md) · [Insiders](/companies/btsg/insiders.md)

## Reports and events: 63 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 86, 8-K 34, 3 20, SCHEDULE 13G/A 10, 10-Q 9, 424B7 8, S-1/A 6, 144 5, CORRESP 5, DRS/A 5, SCHEDULE 13D/A 5, UPLOAD 4, 10-K 3, DEFA14A 3, DRSLTR 3, SC 13G 3, SCHEDULE 13G 3, 424B4 2, 4/A 2, ARS 2, DEF 14A 2, DRS 2, S-1 2, 8-A12B 1, 8-K/A 1, CERT 1, D 1, EFFECT 1, FWP 1, RW 1, S-3ASR 1, S-8 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 08:45 ET | [10-Q](/filings/0001865782-26-000012.md) | Quarterly report, period 2026-09-30 | 0001865782-26-000012 |
| 2026-10-30 | 06:05 ET | [8-K](/filings/0001865782-26-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001865782-26-000011 |
| 2026-07-31 | 08:45 ET | [10-Q](/filings/0001193125-26-327014.md) | Quarterly report, period 2026-06-30 | 0001193125-26-327014 |
| 2026-07-31 | 06:05 ET | [8-K](/filings/0001193125-26-326654.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-326654 |
| 2026-06-12 | 16:05 ET | [8-K](/filings/0001193125-26-269360.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-269360 |
| 2026-06-05 | 17:21 ET | [SCHEDULE 13D/A](/filings/0001140361-26-024308.md) | Ownership report, active investor, amended | 0001140361-26-024308 |
| 2026-06-05 | 16:05 ET | [8-K](/filings/0001193125-26-259531.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-259531 |
| 2026-05-21 | 16:15 ET | [8-K](/filings/0001193125-26-234435.md) | 5.07 Shareholder vote results | 0001193125-26-234435 |
| 2026-05-01 | 08:45 ET | [10-Q](/filings/0001193125-26-199339.md) | Quarterly report, period 2026-03-31 | 0001193125-26-199339 |
| 2026-05-01 | 06:05 ET | [8-K](/filings/0001193125-26-198983.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-198983 |
| 2026-04-10 | 16:00 ET | [DEF 14A](/filings/0001193125-26-151207.md) | Proxy statement, period 2026-04-10 | 0001193125-26-151207 |
| 2026-03-31 | 07:40 ET | [8-K](/filings/0001193125-26-133307.md) | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-133307 |
| 2026-03-04 | 19:37 ET | [SCHEDULE 13D/A](/filings/0001140361-26-007942.md) | Ownership report, active investor, amended | 0001140361-26-007942 |
| 2026-03-04 | 16:05 ET | [8-K](/filings/0001865782-26-000008.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001865782-26-000008 |
| 2026-02-27 | 08:46 ET | [10-K](/filings/0001193125-26-079454.md) | Annual report, period 2025-12-31 | 0001193125-26-079454 |
| 2026-02-27 | 06:05 ET | [8-K](/filings/0001193125-26-078998.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-078998 |
| 2025-10-28 | 16:35 ET | [10-Q](/filings/0001193125-25-253631.md) | Quarterly report, period 2025-09-30 | 0001193125-25-253631 |
| 2025-10-28 | 16:10 ET | [8-K](/filings/0001193125-25-253503.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-253503 |
| 2025-10-22 | 17:12 ET | [SCHEDULE 13D/A](/filings/0001140361-25-038959.md) | Ownership report, active investor, amended | 0001140361-25-038959 |
| 2025-10-22 | 16:05 ET | [8-K](/filings/0001193125-25-246752.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-246752 |
| 2025-10-20 | 16:20 ET | [8-K](/filings/0001193125-25-243598.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-243598 |
| 2025-08-01 | 08:46 ET | [10-Q](/filings/0000950170-25-101119.md) | Quarterly report, period 2025-06-30 | 0000950170-25-101119 |
| 2025-08-01 | 06:05 ET | [8-K](/filings/0000950170-25-101093.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-101093 |
| 2025-06-26 | 16:31 ET | [SCHEDULE 13D/A](/filings/0001140361-25-023832.md) | Ownership report, active investor, amended | 0001140361-25-023832 |
| 2025-06-20 | 17:15 ET | [8-K](/filings/0000950170-25-088587.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-088587 |
| 2025-06-12 | 19:35 ET | [SCHEDULE 13D/A](/filings/0001140361-25-022342.md) | Ownership report, active investor, amended | 0001140361-25-022342 |
| 2025-06-12 | 16:19 ET | [8-K](/filings/0000950170-25-085363.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-085363 |
| 2025-06-10 | 16:03 ET | [8-K](/filings/0000950170-25-084281.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-084281 |
| 2025-06-03 | 17:15 ET | [8-K](/filings/0000950170-25-081109.md) | 5.07 Shareholder vote results | 0000950170-25-081109 |
| 2025-05-02 | 08:00 ET | [10-Q](/filings/0000950170-25-062263.md) | Quarterly report, period 2025-03-31 | 0000950170-25-062263 |
| 2025-05-02 | 06:05 ET | [8-K](/filings/0000950170-25-062245.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-062245 |
| 2025-04-18 | 16:32 ET | [DEF 14A](/filings/0000950170-25-055886.md) | Proxy statement, period 2025-05-28 | 0000950170-25-055886 |
| 2025-04-15 | 17:15 ET | [8-K/A](/filings/0000950170-25-054320.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-054320 |
| 2025-03-06 | 08:40 ET | [10-K](/filings/0000950170-25-034196.md) | Annual report, period 2024-12-31 | 0000950170-25-034196 |
| 2025-03-06 | 06:05 ET | [8-K](/filings/0000950170-25-034152.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-034152 |
| 2025-03-05 | 17:20 ET | [8-K](/filings/0000950170-25-033847.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-033847 |
| 2025-01-21 | 06:03 ET | [8-K](/filings/0000950170-25-006965.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-006965 |
| 2024-12-11 | 16:10 ET | [8-K](/filings/0000950170-24-135375.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-135375 |
| 2024-11-15 | 17:20 ET | [8-K](/filings/0000950170-24-127696.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-127696 |
| 2024-11-01 | 08:55 ET | [10-Q](/filings/0000950170-24-119820.md) | Quarterly report, period 2024-09-30 | 0000950170-24-119820 |
| 2024-11-01 | 06:05 ET | [8-K](/filings/0000950170-24-119790.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-119790 |
| 2024-10-11 | 17:21 ET | [8-K](/filings/0000950170-24-114404.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-114404 |
| 2024-09-30 | 07:30 ET | [8-K](/filings/0000950170-24-110168.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-110168 |
| 2024-09-18 | 18:24 ET | [SC 13D](/filings/0001140361-24-041401.md) | Ownership report, active investor | 0001140361-24-041401 |
| 2024-08-02 | 08:50 ET | [10-Q](/filings/0000950170-24-089623.md) | Quarterly report, period 2024-06-30 | 0000950170-24-089623 |
| 2024-08-02 | 06:10 ET | [8-K](/filings/0000950170-24-089576.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-089576 |
| 2024-06-24 | 16:35 ET | [8-K](/filings/0000950170-24-076783.md) | 3.02 Unregistered sale of equity | 0000950170-24-076783 |
| 2024-05-31 | 16:38 ET | [8-K](/filings/0000950170-24-067369.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-067369 |
| 2024-05-02 | 08:55 ET | [10-Q](/filings/0000950170-24-051607.md) | Quarterly report, period 2024-03-31 | 0000950170-24-051607 |
| 2024-05-02 | 06:14 ET | [8-K](/filings/0000950170-24-051549.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-051549 |

Page 1 of 2. [Older](/companies/btsg/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 31, 2026, 15:25 ET. No prices; not investment advice.